Hepatic disposition and metabolite kinetics of a homologous series of diflunisal esters

Journal of Pharmaceutical Sciences

Volumn 87, Issue 8, 1998, Pages 943-951

  Hung, Daniel Y ^a   Mellick, George D ^a   Anissimov, Yuri G ^a   Weiss, Michael ^b   Roberts, Michael S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIFLUNISAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BINDING; DRUG DISPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER METABOLISM; LIVER PERFUSION; NONHUMAN; PORTAL VEIN; RAT;

EID: 0031875143     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970485y     Document Type: Article

References (23)

1. Chou, C. H.; Evans, A. M.; Fornasini, G.; Rowland, M. Relationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver. Drug. Metab. Disp. 1993, 21, 933-938.
2. Chou, C. H.; McLachlan, A. J.; Rowland, M. Membrane permeability and lipophilicity in the isolated perfused rat liver: 5-ethyl barbituric acid and other compounds. J. Pharm. Exp. Ther. 1995, 275, 933-940.
3. Hung, D. Y.; Mellick, G. D.; Weiss, M.; Roberts, M. S. Hepatic structure-pharmacokinetic relationships: The hepatic disposition and metabolite kinetics of a homologous series of O-acyl derivatives of salicylic acid. Br. J. Pharmacol., in press.
4. Lecomte, M.; Laneuville, O.; Ji, C.; Dewitt, D. L.; Smith, W. L. Acetylation of human prostaglandin endoperoxide synthase-2 by aspirin. J. Biol. Chem. 1994, 269, 13207-13215.
5. Siebert, D. J.; Bochner, F.; Imhoff, D. M.; Watts, S.; Lloyd, J. V.; Field, J.; Gabb, B. W. Aspirin kinetics and platelet aggregation in man. Clin. Pharmacol. Ther. 1983, 33, 367-374.
6. Pedersen, A. K.; Fitzgerald, G. A. Dose-related kinetics of aspirin. New Eng. J. Med. 1984, 8, 1206-1211.
7. Roberts, M. S.; Joyce, R. M.; McLeod, L. J.; Vial, J. H.; Seville, P. R. Slow-release aspirin and prostaglandin inhibition. Lancet. 1986, (i), 1153-1154.
8. McLeod, L. J.; Roberts, M. S.; Seville, P. R. Low-dose enteric-coated aspirin as an antiplatelet preparation. Med. J. Aust. 1988, 148, 207.
9. Mellick, G. D.; Roberts, M. S. The disposition of aspirin and salicylic acid in the isolated perfused rat liver: The effect of normal and retrograde flow on availability and mean transit times. J. Pharm. Pharmacol. 1996, 48, 738-743.
10. Tempero, K. F.; Cirillo, V. J.; Steelman, S. L. Diflunisal: A review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans. Br. J. Clin. Pharmacol. 1977, 4, 31S-36S.
11. Hung, D. Y.; Mellick, G. D.; Prankerd, R. J.; Roberts M. S. Synthesis, identification, characterization, protein binding and stability of ester derivatives of salicylic acid and diflunisal. Int. J. Pharm. 1997, 153, 25-39.
12. Yano, Y.; Yamaoka, K.; Minamide, T.; Nakagawa, T.; Tanaka, H. Evaluation of protein binding effect on local disposition of oxacillin in rat liver by a two-compartment dispersion model. J. Pharm. Pharmacol. 1990, 42, 632-636.
13. Evans, A. M.; Hussein, Z.; Rowland, M. Influence of albumin on the distribution and elimination kinetics of diclofenac in the isolated perfused rat liver: analysis by the impulse-response technique and the dispersion model. J. Pharm. Sci. 1993, 82, 421-428.
14. Hussein, Z.; McLachlan, A. J.; Rowland, M. Distribution kinetics of salicylic acid in the isolate perfusated rat liver assessed using moments analysis and the two-compartment axial dispersion model. Pharm. Res. 1994, 11, 1337-1345.
15. Gillette, J. R. Factors affecting drug metabolism. Ann. N. Acad. Sci. 1971, 179, 43-61.
16. Weiss, M.; Stedtler, C.; Roberts, M. S. On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed. Bull. Math. Biol. 1997, 59, 911-929.
17. Mellick, G. D.; Anissimov, Y. G.; Bracken, A. G.; Roberts, M. S. Metabolite mean transit times in the liver as predicted by various models of hepatic elimination. J. Pharm. Biopharm. 1998, in press.
18. Purves, R. D. Numerical estimation of the noncompartmental parameters variance (VRT) and coefficient of variation (CVRT) of residence times. J. Pharm. Sci. 1994, 83, 202-205.
19. Roberts, M. S.; Fraser, S.; Wagner, A.; McLeod, L. Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate. J. Pharmacokin. Biopharm. 1990, 18, 209-234.
20. Cheung, K.; Hickman, P. E.; Potter, J. M.; Walker, N. I.; Jericho, M.; Haslam, R.; Roberts, M. S. An optimized model for rat liver perfusion studies. J. Surg. Res. 1996, 66, 81-89.
21. Dickinson, R. G.; King, A. R. Studies on the reactivity of acyl glucuronides: Glucuronide-derived covalent binding of diflunisal to bladder tissue of rats and its modulation by urinary pH and beta-glucuronidase. Biochem. Pharmacol. 1993, 46, 1175-1182.
22. Watt, J. A.; Dickinson, R. G. The effect of diethyl ether, pentobarbitone and urethane anaesthesia on diflunisal conjugation and disposition in rats. Xenobiotica 1990, 20, 289-301.
23. Roberts, M. S.; and Rowland, M. Correlation between in vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model. J. Pharm. Pharmacol. 1986, 38, 177-181.